La. Nolten et al., HEPATOCYTE NUCLEAR FACTOR-1-ALPHA ACTIVATES PROMOTER-1 OF THE HUMAN INSULIN-LIKE GROWTH-FACTOR-I GENE VIA 2 DISTINCT BINDING-SITES, Molecular endocrinology, 9(11), 1995, pp. 1488-1499
Expression of the human insulin-like growth factor I (hIGF-I) gene is
regulated in a tissue-and developmental stage-specific manner. The hIG
F-I gene has two promoters, P1 and P2. P1 is the more active promoter
by far in adult liver, the main endocrine source of IGF-I. Recently, w
e described the involvement of the CAAT/enhancer binding protein famil
y of liver-enriched transcription factors in the regulation of the exp
ression of IGF-I in adult liver. In this study we report on the role o
f another family of liver-enriched transcription factors in the regula
tion of IGF-I expression. Hepatocyte nuclear factor 1 alpha (HNF-1 alp
ha) is shown to transactivate IGF-I P1 in transient transfection exper
iments performed in Hep3B cells. Bandshift experiments reveal that two
distinct regions in P1, located 119 and 282 nucleotides upstream of t
he transcription start site, can bind HNF-1 alpha with relatively high
affinity. Both HNF-1-binding sites are evolutionary well conserved, e
mphasizing the importance of HNF-1 in the regulation of the IGF-I gene
expression. Mutational analysis of the binding sites indicates that b
oth sites are essential for maximal stimulation of P1 by HNF-1 alpha a
lthough the largest contribution stems from the more downstream of the
two HNF-1-binding sites. The latter site completely overlaps the prev
iously described CAAT/enhancer binding protein binding site in P1. The
colocalization of the binding sites, to which binding of the respecti
ve factors seems to be mutually exclusive, is suggestive of a regulato
ry hotspot to which members of different transcription factor families
may bind depending on developmental stage and nutritional status.